About Rubicor Medical

Rubicor Medical is a private medical device company located in Redwood City, California. Our proprietary biopsy technology (Ovation Breast Biopsy Device) is a dramatic improvement over current minimally invasive biopsy technologies. The Ovation system is comprised of a 14-gauge biopsy device capable of excising, capturing and extracting an intact 2.5 cm diameter tissue sample. Ovation is compatible with either ultrasound or stereotactic image guidance. Rubicor was co-founded by Dr. James Vetter and has been privately funded by a consortium of individual investors.James W. Vetter, M.D., CEO and Chairman of the Board, is a board certified interventional cardiologist.He is an Associate Professor of Clinical Medicine at Stanford University Hospital, where he iscurrently on Active Staff status as community faculty. Dr. Vetter is a graduate of the MedicalCollege of Wisconsin where he completed a residency in internal medicine and a fellowship incardiology. Dr. Vetter completed an interventional cardiology fellowship with Dr. John SimpsonM.D./PhD., at Sequoia Hospital, Redwood City, California. Dr. Vetter is a member of the Alpha OmegaAlpha Honor Society and the American College of Cardiologists. He has published six articles andseveral book chapters as well as over 35 abstracts. Dr. Vetter has held positions as a member of thePhysician Advisory Council and/or board member with a number of medical device companiesincluding Guidant, Lumend, Fox Hollow and CardioVasc. He is also a board member of MagellanSystems International, Inc.Dr. Vetter has extensive experience in working with new medical device concepts and designs,working with R&D engineers to develop working prototypes and clinically testing and refining thoseproducts. He was co-founder of Perclose and was involved with that company from inception toinitial public offering and eventual sale to Abbott Labs. He is a "hands on" clinician with access toresources and expertise needed to build a successful medical device and company. Dr. Vetter hashad a number of patents issued in his name as co-inventor.Ary Chernomorsky, V.P. of R&D since 2000 has over 23 years experience in the medical deviceindustry. Prior to joining Rubicor, Mr. Chernomorsky was employed by the Vascular Therapiesdivision of US Surgical Company (acquired by Tyco International), where he served as a Director ofR&D. Mr. Chernomorsky has been involved with various startup companies in the R&D Director andManager capacities including: PAS Inc. (acquired by USS), Advanced Surgical, Inc. (acquired byImagyn), Micro Therapeutics, Bausch and Lomb, Mentor Corporation and Dart Industries Inc. Aryholds an M.S. in Polymer Engineering from LIT and an M.S. in Biomedical Engineering from RutgersUniversity.Tony Difede, CPA, V.P. Finance holds a BSBA degree in Accounting from the University of Floridaand a M.S. in Taxation from Pace University. He has held management positions in tax and accountingwith Ernst & Young, KPMG and my CFO, Inc. His clients have included closely held start-upcompanies as well as large multinational public corporations. He is licensed in California and NewJersey. He has extensive experience in accounting for stock options and issues regarding closelyheld companies and their high net worth owners and investors.COMPANY INFOMANAGEMENTpage 12006 Company Overview (Continued)Breast care. Completely redefined.James W. Vetter, M.D., Founder and Chairman of the Board, is a board certified interventionalcardiologist. He is an Associate Professor of Clinical Medicine at Stanford University Hospital,where he is currently on Active Staff status as community faculty. Dr. Vetter is a graduate of theMedical College of Wisconsin where he completed a residency in internal medicine and a fellowshipin cardiology. Dr. Vetter completed an interventional cardiology fellowship with Dr. JohnSimpson M.D./PhD., at Sequoia Hospital, Redwood City, Cal